Skip to main content

EDITORIAL article

Front. Pharmacol.
Sec. Drug Metabolism and Transport
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1451176
This article is part of the Research Topic Pharmacokinetic-Pharmacodynamic Model of Drugs and Their Pharmacokinetic Differences between Normal and Disease States View all 15 articles

Editorial: Pharmacokinetic-Pharmacodynamic Model of Drugs and Their Pharmacokinetic Differences between Normal and Disease States

Provisionally accepted
  • 1 Guizhou Medical University, Guiyang, China
  • 2 Southern Medical University, Guangzhou, Guangdong, China
  • 3 Fudan University, Shanghai, Shanghai Municipality, China
  • 4 The Chinese University of Hong Kong, Shatin, Hong Kong Region, China
  • 5 Boundless Bio Inc., San Diego, United States

The final, formatted version of the article will be published soon.

    Keywords: Normal status, Disease states, metabolizing enzymes, transporters, Pharmacokinetic-pharmacodynamic link model

    Received: 18 Jun 2024; Accepted: 27 Jun 2024.

    Copyright: © 2024 Gong, Chen, Ye, Ma, Xian and Kulkarni. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zipeng Gong, Guizhou Medical University, Guiyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.